-
1361
Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria
Published 2017-05-01“…The study was a prospective, randomized, double-blind, placebo-controlled, phase IIa trial of rosiglitazone (0.045 mg/kg/dose) twice daily for 4 days versus placebo as adjunctive treatment in addition to Mozambican standard of care (artemisinin combination therapy Coartem®) in children with uncomplicated malaria. …”
Get full text
Article -
1362
Investigating the Presence of Falsified and Poor-Quality Fixed-Dose Combination Artemether-Lumefantrine Pharmaceutical Dosage Forms in Kumasi, Ghana
Published 2024-01-01“…Artemether-lumefantrine (AL) is a highly effective and commonly used Artemisinin-based Combination Therapy (ACT) for treating uncomplicated malaria caused by Plasmodium falciparum, including drug-resistant strains. …”
Get full text
Article -
1363
-
1364
Zinc-metal–organic frameworks with tunable UV diffuse-reflectance as sunscreens
Published 2022-02-01Get full text
Article -
1365
Planetary Health and Traditional Medicine: A Potential Synergistic Approach to Tackle Antimicrobial Resistance
Published 2022-06-01“…Examples include the recent discovery of Artemisinin, a highly active antimalarial drug derived from <i>Artemisia annua</i>, and the discovery of Taxol, an active chemotherapeutic drug derived from the bark of the Pacific yew, <i>Taxus brevifolia</i>. …”
Get full text
Article -
1366
MYC2: A Master Switch for Plant Physiological Processes and Specialized Metabolite Synthesis
Published 2023-02-01“…Based on our understanding of the mechanism underlying the regulation of specialized metabolite synthesis in plants by the transcription factor MYC2, the use of synthetic biology approaches to design MYC2-driven chassis cells for the synthesis of specialized metabolites with high medicinal value, such as paclitaxel, vincristine, and artemisinin, seems to be a promising strategy. In this review, the regulatory role of MYC2 in JA signal transduction of plants to biotic and abiotic stresses, plant growth, development and specialized metabolite synthesis is described in detail, which will provide valuable reference for the use of MYC2 molecular switches to regulate plant specialized metabolite biosynthesis.…”
Get full text
Article -
1367
Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
Published 2011-03-01“…However, limited data are available on the effectiveness of using artemisinin-based combination therapy (ACT) within the HMM strategy. …”
Get full text
Article -
1368
Are rapid diagnostic tests more accurate in diagnosis of <it>plasmodium falciparum </it>malaria compared to microscopy at rural health centres?
Published 2010-12-01“…<p>Abstract</p> <p>Background</p> <p>Prompt, accurate diagnosis and treatment with artemisinin combination therapy remains vital to current malaria control. …”
Get full text
Article -
1369
Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria
Published 2022-07-01“…About 627,000 patients died of malaria in 2020. Currently, artemisinin and its derivatives are the front-line drugs used for the treatment of cerebral malaria. …”
Get full text
Article -
1370
Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to...
Published 2022-11-01“…As an alternative, the intermittent screening and treatment for pregnancy (ISTp) aims at a monthly screening of pregnant women, preferably by using very sensitive tests such as ultrasensitive rapid diagnostic tests (us-RDTs) and the treatment of positive cases with artemisinin-based combination therapy (ACT) regardless of the presence of symptoms. …”
Get full text
Article -
1371
Dietary phytochemicals: As a potential natural source for treatment of Alzheimer's Disease
Published 2023-01-01“…In this study, several representatives’ dietary phytochemicals with anti-AD effect, including resveratrol, lycopene, gallic acid, berberine, ginsenoside Rg1, pseudoginsenoside-F11, ginsenoside Rh2, artemisinin, and torularhodin were selected from the published data over the last 10 years and their potential molecular mechanisms and clinical applications reviewed in the treatment of AD.…”
Get full text
Article -
1372
Assessment of the performance and challenges in the implementation of the test, treat and track (T3) strategy for malaria control among children under-five years in Ghana
Published 2022-01-01“…<h4>Background</h4> The World Health Organization recommended the Test, Treat and Track (T3) strategy for malaria control that, every suspected malaria case should be tested prior to treatment with Artemisinin-based combination therapy (ACT) and tracked. …”
Get full text
Article -
1373
Efficacy of antimalarial herbal medicines used by communities in malaria affected regions globally: a protocol for systematic review and evidence and gap map
Published 2023-07-01“…Introduction With the rising resistance to artemisinin-based combination treatments, there is a need to hasten the discovery and development of newer antimalarial agents. …”
Get full text
Article -
1374
<i>Artemisia annua</i> Growing Wild in Romania—A Metabolite Profile Approach to Target a Drug Delivery System Based on Magnetite Nanoparticles
Published 2021-10-01“…Various studies focused on artemisinin and its derivates for their antiparasitic and antitumoral effects. …”
Get full text
Article -
1375
-
1376
Impact of school-based malaria case management on school attendance, health and education outcomes: a cluster randomised trial in southern Malawi
Published 2020-01-01“…The intervention, implemented in 29 randomly selected schools, provided malaria rapid diagnostic tests and artemisinin-based combination therapy to diagnose and treat uncomplicated malaria as part of basic first aid kits known as ‘Learner Treatment Kits’ (LTK). …”
Get full text
Article -
1377
Anti-malarial market and policy surveys in sub-Saharan Africa
Published 2010-04-01“…<p>Abstract</p> <p>At a recent meeting (Sept 18, 2009) in which reasons for the limited access to artemisinin-based combination therapy (ACT) in sub-Saharan Africa were discussed, policy and market surveys on anti-malarial drug availability and accessibility in Burundi and Sierra Leone were presented in a highly interactive brainstorming session among key stakeholders across private, public, and not-for-profit sectors. …”
Get full text
Article -
1378
Dihydroartemisinin ameliorates innate inflammatory response induced by Streptococcus suis-derived muramidase-released protein via inactivation of TLR4-dependent NF-κB signaling
Published 2023-10-01“…Dihydroartemisinin (DhA) is an artemisinin derivative with potential anti-inflammatory activity. …”
Get full text
Article -
1379
Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand
Published 2022-11-01“…Results Among the samples whose kelch13 were successfully sequenced, approximately half (31/55; 56%) had mutation associated with artemisinin resistance, including G533S (23/55; 42%), C580Y (6/55; 11%), and G538V (2/55; 4%). …”
Get full text
Article -
1380
The evolution of pyrimethamine resistant <it>dhfr </it>in <it>Plasmodium falciparum </it>of south-eastern Tanzania: comparing selection under SP alone <it>vs </it>SP+artesunate com...
Published 2011-10-01“…<p>Abstract</p> <p>Background</p> <p>Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and southern Africa and artemisinin compounds in combination with synthetic drugs (ACT) are recommended as replacement treatments by the World Health Organization (WHO). …”
Get full text
Article